HOPE Therapeutics, wholly owned by NRx Pharmaceuticals (NRXP), announced signing of a binding Letter of Intent, LOI, to acquire a majority interest in Neurospa TMS Holdings. Neurospa operates six ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback